Publication: Efficacy and tolerability of 20% aluminum sesquichlorohydrate vs 20% aluminum chloride for the treatment of axillary hyperhidrosis: A randomized controlled trial
0
0
Issued Date
2020
Resource Type
File Type
application/pdf
ISSN
13960296
Other identifier(s)
2-s2.0-85092284609
Rights
Srinakharinwirot University
Rights Holder(s)
Scopus
Bibliographic Citation
Dermatologic Therapy. Vol 33, No.6 (2020)
Suggested Citation
Thianboonsong T., Kanokrungsee S., Paichitrojjana A., Udompataikul M., Kamanamool N., Rojhirunsakool S. Efficacy and tolerability of 20% aluminum sesquichlorohydrate vs 20% aluminum chloride for the treatment of axillary hyperhidrosis: A randomized controlled trial. Dermatologic Therapy. Vol 33, No.6 (2020). doi:10.1111/dth.14354 Retrieved from: https://hdl.handle.net/20.500.14740/5817
Abstract
This study evaluated the efficacy and tolerability of topical aluminum sesquichlorohydrate (AS) when compared to aluminum chloride (AC) as a treatment for primary axillary hyperhidrosis (PAH). Twenty subjects were included in this randomized, controlled, split-side 8-week study. All participants applied 20% AS and 20% AC lotions in their axillae (one treatment per axilla) every night for 2 weeks; next, the application was reduced to three times a week for 4 weeks. The assessment was performed using the sweating intensity visual scale (SIVS), hyperhidrosis disease severity score (HDSS), patient satisfaction score, and the appearance of adverse effects on weeks 0, 1, 2, 4, 6, and 8. Both AS as well as AC application showed positive results, significantly differing from the baseline, as assessed using SIVS, HDSS, and patient satisfaction score at every follow-up visit; however, no significant difference was observed between the AS and AC groups at any follow-up visit. The mean time of response was 1.14 weeks for both treatments. A side effect was observed in one subject (5%), who reported itching on the AC axilla. The therapeutic effects persisted even after reducing the frequency of application and lasted for at least 2 weeks after cessation of use. In conclusion, topical 20% AS demonstrated similar efficacy to topical 20% AC in the treatment of PAH, with a high safety profile. © 2020 Wiley Periodicals LLC.
Subject(s)
Aluminum chloride
Aluminum salt
Aluminum sesquichlorohydrate
Antiperspirant agent
Non prescription drug
Unclassified drug
Adult
Article
Axilla
Clinical article
Clinical evaluation
Clinical observation
Comparative effectiveness
Controlled study
Disease severity assessment
Double blind procedure
Drug efficacy
Drug safety
Drug tolerability
Female
Follow up
Human
Hyperhidrosis
Hyperhidrosis disease severity score
Lotion
Low level laser therapy
Male
Night
Patient satisfaction
Prospective study
Pruritus
Randomized controlled trial
Skin disease assessment
Sweating intensity visual scale
Therapy effect
Topical treatment
Treatment response
Aluminum salt
Aluminum sesquichlorohydrate
Antiperspirant agent
Non prescription drug
Unclassified drug
Adult
Article
Axilla
Clinical article
Clinical evaluation
Clinical observation
Comparative effectiveness
Controlled study
Disease severity assessment
Double blind procedure
Drug efficacy
Drug safety
Drug tolerability
Female
Follow up
Human
Hyperhidrosis
Hyperhidrosis disease severity score
Lotion
Low level laser therapy
Male
Night
Patient satisfaction
Prospective study
Pruritus
Randomized controlled trial
Skin disease assessment
Sweating intensity visual scale
Therapy effect
Topical treatment
Treatment response